Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 3/20 | 0.57 |
| ▸ | F2 | P00734 | 1/20 | 0.57 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.55 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31462032 | 0.96 | OPRM1 (0.61) | OPRM1F2OPRD1OPRK1POLB | |
| SCHEMBL29349609 | 0.90 | POLB (0.68) | OPRM1F2OPRD1OPRK1POLB | |
| SCHEMBL31316687 | 0.89 | OPRM1 (0.63) | OPRM1OPRD1 | |
| SCHEMBL29780362 | 0.88 | OPRM1 (0.69) | OPRM1OPRD1 | |
| SCHEMBL29630582 | 0.88 | GRB2 (0.49) | OPRM1F2OPRD1OPRK1 | |
| SCHEMBL25214575 | 0.87 | OPRM1 (0.64) | OPRM1OPRD1 | |
| SCHEMBL29442415 | 0.87 | OPRM1 (0.64) | OPRM1OPRD1 | |
| SCHEMBL29630585 | 0.87 | SLC6A2 (0.56) | OPRM1F2OPRD1OPRK1POLB | |
| SCHEMBL31412199 | 0.86 | OPRM1 (0.66) | OPRM1OPRD1OPRK1 | |
| SCHEMBL30833622 | 0.86 | OPRM1 (0.66) | OPRM1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3145943-B1 | PEPTIDES, COMPOSITIONS COMPRISING THEM AND USES IN PARTICULAR COSMETIC USES | SEDERMA SA (FR) | 2024-03-13 | — | — | EP | disclosed |
| CN-110742822-B | Skin whitening anti-aging composition, whitening anti-aging cream containing same and preparation method thereof | 广州环亚化妆品科技有限公司 | 2022-04-01 | — | — | CN | disclosed |